Twi
Transaction Case Studies JAPAN COLLABORATION FOR A PHASE 2 ORPHAN DERMATOLOGY ASSET AC-203, A NOVEL TOPICAL TREATMENT FOR EPIDERMOLYSIS BULLOSA […]
Uncategorized
Locust Walk Webinar
2022 Biopharma Capital Outlook: Strategies to Navigate a Shifting Financing & Strategic Marketplace – January 27th, 2022
Locust Walk Stem Cell Tx Conference Locust Walk Stem Cell Tx Conference in partnership with Harvard Stem Cell Institute
Locust Walk Webinar
Has Biotech Peaked? – November 16th, 2021
Has Biotech Peaked? – November 16th, 2021
Locust Walk Webinar
What Biopharma Should Expect From The Public Markets In 2H 2021 – August 11, 2021
Why So Many Biopharma M&A Transactions Start Out as Aspirational Licensing Deals – September 30th, 2021
Locust Walk Webinar
The Evolving Role of Crossover Financing – May 20, 2021
The Evolving Role of Crossover Financing – May 20, 2021
Locust Walk Webinar
Should Biotech Bother With Early-Stage Collaborations Given the Hot Financing Market? – May 5, 2021
Should Biotech Bother With Early-Stage Collaborations Given the Hot Financing Market? – May 5, 2021
Locust Walk Webinar
The Future of Biotech Financing: Continued Boom or Bust? – December 3, 2020
The Future of Biotech Financing: Continued Boom or Bust? – December 3, 2020
Locust Walk Webinar
Knocking At The Door: Challenges Women Face With Biopharma Boards – September 23, 2020
Knocking At The Door: Challenges Women Face With Biopharma Boards – September 23, 2020
Locust Walk Webinar
Brave New World: Challenges from the East, Asia Biopharma, and Response to COVID-19 – July 1, 2020
Brave New World: Challenges from the East, Asia Biopharma, and Response to COVID-19 – July 1, 2020
Locust Walk Webinar
Accessing Capital in the time of COVID: Challenges, Opportunities, and Best Practices – June 11, 2020
Accessing Capital in the time of COVID: Challenges, Opportunities, and Best Practices – June 11, 2020